31 March 2009
URCH Publishing Buys Spectra Intelligence
A Specialist Pharmaceutical Market Research Business
Today, URCH Publishing Ltd (www.urchpublishing.com), a well-respected and established publisher of quality market intelligence reports covering the global pharmaceutical and healthcare industry, acquired Spectra Intelligence, a privately owned publisher of specialised and syndicated pharmaceutical market research. The deal includes a series of pharmaceutical titles, copyrights and license agreements, proprietary datasets, and online platforms. Terms were not disclosed.
Commenting on the deal, Edwin Bailey, Managing Director, URCH Publishing, said: "This acquisition allows us to expand our portfolio of research-driven healthcare industry market reports in the disease and therapeutic sectors, which will complement our current list of market trends reports. In addition, we will be able to offer a more comprehensive platform for subscription-based clients and individual purchasers of business information".
Spectra Intelligence (www.spectraintelligence.com), which was established in 2005, is a leader in biopharma market research providing both syndicated and customised research studies for the global biomedical, pharmaceutical, and allied healthcare industries. Tim Atkinson, Director or Research and Analysis and Founder said: "Spectra Intelligence has built up a well-established portfolio of high quality research-based reports offering valuable insights to the global healthcare industry. This acquisition will complement and expand URCH Publishing's already extensive portfolio of reports in pharmaceuticals and biotechnology, and I am extremely pleased that URCH will continue to carry on producing quality reports under the Spectra Intelligence brand."
From today all queries regarding Spectra Intelligence's business or products should be directed to URCH Publishing. For more information call Edwin Bailey, Managing Director, URCH Publishing Ltd.
